+44 (0)1509 263171
Please use this identifier to cite or link to this item:
|Title: ||Quantification of variation in biological input materials and its effect on clinical outcome and manufacture|
|Authors: ||Thurman-Newell, Jamie A.|
Petzing, Jon N.
Williams, David J.
|Issue Date: ||2013|
|Citation: ||THURMAN-NEWELL, J.A., PETZING, J.A. and WILLIAMS, D.J., 2013. Quantification of variation in biological input materials and its effect on clinical outcome and manufacture. Presented at the Fourth Doctoral Training Centre Joint Conference 2013, 12th July 2013, Sheffield University.|
|Abstract: ||Using blood and blood-based products as a case study, this project will investigate and seek to manage biological input variation from a processing perspective by relating this to clinical outcome (i.e. patient benefit) and exploring the concerns due to input variation when manufacturing a biological therapeutic at multiple sites. • Hematopoietic stem cell transplants are used to treat blood-based cancer and immunological deficiency • Over 130,000 transplants were carried out in Europe between 1990 and 2000 • The living cell is the product, introducing more complexity and sensitivity than found in pharmaceuticals • Humans are the source of the raw material, and we are inherently variable • Variation affects the cost, the safety of the therapeutic and the efficacy of the treatment|
|Description: ||This is a conference paper.|
|Sponsor: ||Funding for this work is provided by an EPSRC grant as part of the Doctoral Training Centre for Regenerative Medicine|
|Appears in Collections:||Conference Papers and Contributions (Mechanical, Electrical and Manufacturing Engineering)|
Files associated with this item:
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.